Skip to main content
S&P 5007,801.77-0.22%DOW51,179.87-0.66%NASDAQ27,538.69-0.22%BTC$83,372.00-2.51%ETH$2,574.91-4.55%GOLD$4,130.50-0.25%OIL$89.24+1.09%
Smart Investors Daily
SID Premium
BL

NASDAQ · BLLN

BillionToOne, Inc.

Healthcare · Medical - Diagnostics & Research

$99.94

Down-$4.19 (-4.19%)

Updated Oct 8, 2026, 1:26 AM

SID Score

5.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
4.42B
P/E ratio
-142.14
Dividend yield
0.00%
52-week range
$61.96 – $150.44
Volume
1.12M
Avg. volume
256.93K

Price performance · BLLN

BLLN price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

BLLN closed at $99.94 after 20 trading sessions, up 0.79% for the selected period.

Last close
$99.94
Period change
+0.79%
Period low
$98.51
Period high
$124.90
Daily close
View OHLC price history
BLLN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$107.86$112.8699$98.90$99.941.12M
Oct 5, 2026$105.15$110.09$104.42$109.06407.8K
Oct 2, 2026$106.39$109.38$102.91$105.90418.3K
Oct 1, 2026$105.67$108.58$103.51$105.76586.95K
Sep 30, 2026$118.48$118.48$105.61$106.44968.84K
Sep 29, 2026$121.72$124.60$118.00$118.18440.45K
Sep 28, 2026$120.64$125.00$119.051$121.72343.64K
Sep 25, 2026$125.19$127.50$123.00$123.08528.14K
Sep 24, 2026$112.33$127.715$112.33$124.90998.27K
Sep 23, 2026$116.00$117.19$113.554$114.42397.7K
Sep 22, 2026$104.00$118.72$102.75$116.071.12M
Sep 21, 2026$106.61$107.21$103.62$103.86412.7K
Sep 18, 2026$112.16$113.00$104.75$105.921.94M
Sep 17, 2026$105.36$111.00$104.485$110.67547.32K
Sep 16, 2026$104.47$106.5083$102.80$103.61398.5K
Sep 15, 2026$101.74$106.04$101.47$104.27375.58K
Sep 14, 2026$98.00$101.98$97.985$100.82420.33K
Sep 11, 2026$99.37$100.8291$95.225$98.77406.06K
Sep 10, 2026$97.36$101.51$96.67$98.51729.08K
Sep 9, 2026$97.54$102.98$96.69$99.16559.25K

Latest BLLN news

The latest Smart Investors Daily articles mentioning BLLN.

Stock researchCompany · Overview

BLLN research

Overview

Company profile and research snapshot.

Company profile

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$136.40
Implied upside
—
Analysts
—
BLLN recent ratings
DateFirmRatingTarget
Oct 1, 2026GuggenheimBuy—
Sep 2, 2026Canaccord GenuityBuy—
Aug 6, 2026JP MorganOverweight—
Aug 6, 2026BTIGBuy—
Jun 29, 2026GuggenheimBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 3, 2026

BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk

BillionToOne’s updated analyst narrative now centers on a fresh Fair Value price target of US$128.57, compared with the prior US$122.14 level in this framework. Recent Street research links this adjustment to enthusiasm around the company’s technology and market reach, while also reflecting new questions on reimbursement risk and long term pricing power. As you read on, you will see how these moving pieces shape the evolving story around BillionToOne and what to watch as the narrative changes...

Yahoo · Sep 23, 2026

BillionToOne (BLLN) Stock Could Be A Bargain As It Jumps 30% YTD

BillionToOne has delivered a strong year to date gain, which puts fresh focus on whether the current share price lines up with the cash the business is expected to generate over time. With the valuation lens firmly on its cash flows, you need to ask whether the recent move reflects sustainable fundamentals or simply enthusiasm. The stock is up 30.0% year to date, which raises the stakes on whether today's valuation is adequately supported by the cash it can produce. The business model, which...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By